Mark DiPaolo

CIK 1669816 · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.20M

Companies

3

Total Filings

15

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INVA Director 140,492 $22.74 $3.19M $0 10 2026-05-06
AMRN Director 401 $15.24 $6.1K $0 3 2025-04-22
NOVELION THERAPEUTICS INC. (NVLN) Delisted Director $0 2 2018-08-13

Recent Filings · Page 2 of 2

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-05-24 INVA Grant (A) +16,399 $0 EDGAR
2018-08-13 NOVELION THERAPEUTICS INC. (NVLN) Delisted Grant (A) $0 EDGAR
2018-04-26 INVA Grant (A) +14,249 $0 EDGAR
2018-02-14 INVA Grant (A) +10,517 $0 EDGAR
2017-08-02 NOVELION THERAPEUTICS INC. (NVLN) Delisted Grant (A) $0 EDGAR
Showing 1115 of 15
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.